Management of Hodgkin Lymphoma

Ansell, Stephen M.; Armitage, James O.
March 2006
Mayo Clinic Proceedings;Mar2006, Vol. 81 Issue 3, p419
Academic Journal
Approximately 7350 new cases of Hodgkin lymphoma (HL) are diagnosed annually in the United States. The incidence of HL has a bimodal pattern, with the highest incidence seen in young adults and in elderly patients. The disease is composed of 2 distinct entitles: the more commonly diagnosed classical HL and the rare nodular lymphocyte-predominant HL. Classical HL includes the subgroups nodular sclerosis, mixed cellularity, lymphocyte depletion, and lymphocyte rich. Selection of the appropriate therapy is based on accurately assessing the stage of disease. Patients with early-stage disease are treated with combined modality strategies using abbreviated courses of combination chemotherapy followed by involved-field radiation therapy, whereas those with advanced-stage disease receive a longer course of chemotherapy without radiation therapy. Currently, more than 80% of all patients with newly diagnosed HL are expected to be long-term survivors. Although many patients respond well to initial therapies and have durable long-term remissions, a subset of patients has resistant disease and experiences relapse even after subsequent high-dose chemotherapy and autologous stem cell transplantation. New therapies are clearly needed for these patients.


Related Articles

  • Primary epidural lymphocyte-depleted Hodgkin's lymphoma of the thoracic spine - presentation of a rare disease variant. Kasper, Ekkehard M.; Lam, Fred C.; Luedi, Markus M.; Zinn, Pascal O.; Pihan, German A. // BMC Neurology;2012, Vol. 12 Issue 1, p64 

    Background: Lymphocyte-depleted Hodgkin's lymphoma is the rarest form of classical Hodgkin's lymphoma, accounting for < 1% of all cases. Patients often have advanced-stage disease at the time of presentation with an aggressive clinical course. Even more uncommon is primary extranodal disease and...

  • Hodgkin lymphoma in Tyrol—a population-based study. Fong, Dominic; Steurer, Michael; Greil, Richard; Gunsilius, Eberhard; Spizzo, Gilbert; Gastl, Guenther; Tzankov, Alexandar // Annals of Hematology;May2009, Vol. 88 Issue 5, p449 

    We aimed to analyze the epidemiology, clinical characteristics, and outcome of patients with Hodgkin lymphoma (HL) diagnosed in Tyrol. All patients with newly diagnosed HL between 1993 and 2005 were included in this study. Among the 158 cases included, nodular lymphocytic predominant HL (nodular...

  • A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma. Raemaekers, J.; Strobbe, L.; Valke, L.; Diets, I.; Brand, M.; Hebeda, K.; Krieken, J.; Aben, K.; Valke, L L F G; Diets, I J; van den Brand, M; Raemaekers, J M M; Hebeda, K M; van Krieken, J H J M // Annals of Hematology;Feb2016, Vol. 95 Issue 3, p417 

    Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a subtype of Hodgkin lymphoma characterized by a unique clinical and histological presentation. Because of the rare nature of this disease, few large-scale studies are available. We conducted a cohort study in which patients were...

  • Dual B and T markers on lymphocytes in fulminant nodular lymphoma. Kirov, S.M.; Lowenhthal, R.M. // British Medical Journal;11/27/1976, Vol. 2 Issue 6047, p1295 

    Examines the importance of B and T-lymphocyte markers in diagnosing fulminant lymphocytic lymphoma. Presence of B lymphocytes within the bone marrow; Contents of thymus with T lymphocytes; Evaluation of tests for lymphocyte surface markers.

  • A Cutaneous Nodule on the Left Temple. Jaiswal, Vilkesh R.; Amirkhan, Robin H.; Hoang, Mai P. // Archives of Pathology & Laboratory Medicine;Dec2003, Vol. 127 Issue 12, pe432 

    Presents a pathologic case study of cutaneous lymphadenoma seen in an old man with nodule on the left temple. Clinical history of the patient; Results of physical and laboratory examinations performed on the patient; Background on the disease.

  • Serum Levels of Interleukin-6 in Patients with Cutaneous Polyarteritis Nodosa. Kawakami, Tamihiro; Takeuchi, Sora; Soma, Yoshinao // Acta Dermato-Venereologica;2012, Vol. 92 Issue 3, p322 

    The article presents a case study of an 88-year-old woman with non Hodgkin's lymphoma (NHL) who underwent a surgery for the excision of mass from her breast. After skin biopsy, she was diagnosed with homogenous, eosinophillic nodular deposit of amyloid in the dermis in association with blood...

  • Phenytoin.  // Reactions Weekly;Mar2014, Vol. 1491 Issue 1, p26 

    An abstract of the article "Nodular lymphocyte predominant Hodgkin lymphoma and diphenylhydantoin: Report of a case and review of the literature," by S. Sharma and colleagues is presented.

  • Hodgkin's Disease: Intramedullary Phagocytosis with Pancytopenia. Korman, Louis Y.; Smith, J. Robert; Landaw, Stephen A.; Davey, Frederick R. // Annals of Internal Medicine;Jul79, Vol. 91 Issue 1, p60 

    Describes the case of a patient with lymphocyte-depletion Hodgkin's disease in which the destruction of blood elements by intramedullary macrophages resulted in severe, refractory pancytopenia. Finding of a pancytopenia in lymphocyte-depletion Hodgkin's disease; Diseases associated with...

  • Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin’s disease: an independent biological prognostic marker. ten Berge, R L; Oudejans, J J; Dukers, D F; Meijer, J W R; Ossenkoppele, G J; Meijer, C J L M // Leukemia (08876924);Mar2001, Vol. 15 Issue 3, p458 

    Recently, we demonstrated that the presence of high percentages of activated cytotoxic T-lymphocytes (CTLs) in biopsy specimens of both Hodgkin's disease (HD) and ALK negative anaplastic large cell lymphoma (ALCL) is associated with a poor prognosis. To test whether this biological prognostic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics